Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Pharmaniaga BhdXKLS:7081 +1.72%45 Days Inventory is 60.63 as of Mar. 2026, which is 32% below its 10-year median of 89.12. GuruFocus rates XKLS:7081 with a GF Score™ of 45/100 and a GF Value™ of RM0.69 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 116 Medical Distribution companies, Pharmaniaga Bhd ranks worse than 56.03% on this metric.
The historical rank and industry rank for Pharmaniaga Bhd's Days Inventory or its related term are showing as below:
XKLS:7081'
s Days Inventory Range Over the Past 10 Years
Min: 64.01 Med: 89.12 Max: 106
Current: 64.01
During the past 13 years, Pharmaniaga Bhd's highest Days Inventory was 106.00. The lowest was 64.01. And the median was 89.12.
XKLS:7081's Days Inventory is ranked worse than 56.03% of 116
companies
in the Medical Distribution industry
Industry Median: 56.935
vs XKLS:7081: 64.01
Pharmaniaga Bhd's Days Inventory
increased
from Mar. 2025 (58.85) to Mar. 2026 (60.63).
It might indicate that Pharmaniaga Bhd's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Pharmaniaga Bhd's Inventory Turnover for the
three
months ended in Mar. 2026 was 1.50.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Pharmaniaga Bhd's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.59.
Pharmaniaga Bhd (XKLS:7081) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Pharmaniaga Bhd's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Pharmaniaga Bhd's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Pharmaniaga Bhd Days Inventory Related Terms
Pharmaniaga Bhd Days Inventory Historical Data
* Premium members only.
The historical data trend for Pharmaniaga Bhd's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKLS:7081 vs MCK, COR, CAH: Days Inventory Comparison
For the Medical Distribution subindustry, Pharmaniaga Bhd's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pharmaniaga Bhd Days Inventory vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Pharmaniaga Bhd's Days Inventory distribution charts can be found below:
* The bar in red indicates where Pharmaniaga Bhd's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pharmaniaga Bhd (XKLS:7081) has a Days Inventory of 60.63 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Pharmaniaga Bhd and its competitors. This is 32% below median its historical median of 89.12. Over the past decade, Pharmaniaga Bhd's Days Inventory has ranged from 64.01 to 106.00. According to the industry distribution chart, Pharmaniaga Bhd ranks #65 out of 116 companies in the Medical Distribution industry, placing it in the top 56%.
Is Pharmaniaga Bhd's Days Inventory too high?
Pharmaniaga Bhd's current Days Inventory of 60.63 is 32% below median its 10-year median of 89.12. Over the past 10 years, this metric has ranged from a low of 64.01 to a high of 106.00. The Medical Distribution industry median Days Inventory is 56.94. Pharmaniaga Bhd's value of 60.63 is 6.5% above this industry median. Based on the distribution chart, Pharmaniaga Bhd ranks #65 out of 116 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Pharmaniaga Bhd has a GF Score™ of 45/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Pharmaniaga Bhd's Days Inventory compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Pharmaniaga Bhd ranks #65 out of 116 companies for Days Inventory. This places Pharmaniaga Bhd in the lower half of its industry. The industry median Days Inventory is 56.94. Pharmaniaga Bhd's value of 60.63 is 6.5% above this benchmark. Historically, Pharmaniaga Bhd's own Days Inventory has ranged from 64.01 to 106.00 over the past decade. While the company's 10-year median is 89.12 vs. the industry median of 56.94, Pharmaniaga Bhd has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Distribution company?
The median Days Inventory among Medical Distribution companies is 56.94, based on 116 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pharmaniaga Bhd's current Days Inventory of 60.63 is 6.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Pharmaniaga Bhd and its competitors. For the Medical Distribution industry, the median Days Inventory is 56.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pharmaniaga Bhd's current Days Inventory is 60.63, which is 32% below median its own 10-year median of 89.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharmaniaga Bhd stock overvalued right now?
Based on GuruFocus' analysis, Pharmaniaga Bhd (XKLS:7081) is currently considered Significantly Overvalued. The stock's GF Value™ is RM0.69, compared to a current price of RM1.18 — trading 71% above its estimated fair value. The current Days Inventory is 60.63, which is 32% below median its 10-year median of 89.12 and 6.5% above the Medical Distribution industry median of 56.94. Pharmaniaga Bhd's overall GF Score™ is 45/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Pharmaniaga Bhd (XKLS:7081), the current Days Inventory is 60.63 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pharmaniaga Bhd (XKLS:7081) Overvalued in 2026?
Based on GuruFocus' analysis, Pharmaniaga Bhd stock appears to be overvalued.
The current stock price of RM1.18 is trading 71% above its estimated GF Value™ of RM0.69.
GuruFocus considers Pharmaniaga Bhd to be Significantly Overvalued.
Key valuation signals for XKLS:7081:
Days Inventory: 60.63 (32% below median its 10-year median of 89.12)
GF Value™: RM0.69 vs. price of RM1.18 (71% above fair value)
Industry Position: 6.5% above the Medical Distribution median (#65 of 116)
No single metric tells the full story. See the XKLS:7081 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pharmaniaga Bhd is engaged in the manufacture of pharmaceuticals and medical devices. The company is also involved in logistics and distribution. The group operates in three segments - Logistics and distribution, Manufacturing in Malaysia, and Manufacturing and distribution in Indonesia. Maximum revenue is generated by the logistics and distribution segment in Malaysia. The Logistics and distribution segment is engaged in distribution, trading and wholesaling of pharmaceutical and medical products as well as supply and installation of medical and hospital equipment in Malaysia.
45GF Score
Get the complete analysis for XKLS:7081
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:7081 has been successfully added to your 
